TNL Mediagene (TNMG) Research & Development (2022 - 2025)

TNL Mediagene (TNMG) has reported Research & Development for 4 consecutive years, with -$3.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Research & Development fell 2.35% year-over-year to -$3.1 million in Q4 2025; TTM through Dec 2025 was -$12.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$3.1 million, down 2.35% from the prior year.
• Research & Development was -$3.1 million for Q4 2025 at TNL Mediagene, down from -$3.1 million in the prior quarter.
• Over five years, Research & Development peaked at -$2.5 million in Q4 2022 and troughed at -$3.3 million in Q4 2023.
• A 4-year average of -$3.0 million and a median of -$3.1 million in 2024 frame the typical range for Research & Development.
• Across the five-year window, Research & Development tumbled 32.61% in 2023 and grew 8.26% in 2024, its largest moves.
• Over 4 years, Research & Development stood at -$2.5 million in 2022, then plunged by 32.61% to -$3.3 million in 2023, then increased by 8.26% to -$3.1 million in 2024, then retreated by 2.35% to -$3.1 million in 2025.
• The last three Research & Development figures came in at -$3.1 million (Q4 2025), -$3.1 million (Q4 2024), and -$3.3 million (Q4 2023), per Business Quant data.